Viewing StudyNCT00423046



Ignite Creation Date: 2024-05-05 @ 5:16 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00423046
Status: COMPLETED
Last Update Posted: 2020-01-02
First Post: 2007-01-16

Brief Title: Immunogenicity of GlaxoSmithKline Biologicals Human Papillomavirus HPV Vaccine 580299 Versus Mercks Gardasil in Healthy Females 18-45 Years of Age
Sponsor:
Organization: GlaxoSmithKline